1.25Open1.25Pre Close320 Volume48.05K Open Interest26.00Strike Price32.92KTurnover0.00%IV0.16%PremiumNov 22, 2024Expiry Date1.14Intrinsic Value100Multiplier4DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma21.81Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet